Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Foghorn Therapeutics to Present at Connective Tissue Oncology Society Annual Meeting

Foghorn Therapeutics Inc. (FHTX) 
Company Research Source: GlobeNewswire
CAMBRIDGE, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced the Company will share preclinical data for FHD-609, a first-in-class, highly potent and selective degrader of BRD9, at the 2022 Connective Tissue Oncology Society (CTOS) Annual Meeting. The meeting will be held November 16–19, 2022, at the Vancouver Convention Centre in Vancouver, BC, Canada. Presentation Details Title: Preclinical Validation of Target Engagement Assays and Investigation of Mechanistic Impacts of FHD-609, a Clinical-Stage BRD9 Degrader Being Developed for the Treatment of Synovial Sarcoma Poster Number: P 187Date: Thursday, November 17, 2022Time: 5:00–7:00 p.m. PT The poster will be accessible following the presentation under the Science section of the Company’s website. About FHD-609 FHD-609 is a pot Show less Read more
Impact Snapshot
Event Time:
FHTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
FHTX alerts

from News Quantified
Opt-in for
FHTX alerts

from News Quantified